<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Messelmani T</submitter><funding>Agence Nationale de la Recherche</funding><pagination>443</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9495334</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(9)</volume><pubmed_abstract>The 3Rs guidelines recommend replacing animal testing with alternative models. One of the solutions proposed is organ-on-chip technology in which liver-on-chip is one of the most promising alternatives for drug screening and toxicological assays. The main challenge is to achieve the relevant in vivo-like functionalities of the liver tissue in an optimized cellular microenvironment. Here, we investigated the development of hepatic cells under dynamic conditions inside a 3D hydroscaffold embedded in a microfluidic device. The hydroscaffold is made of hyaluronic acid and composed of liver extracellular matrix components (galactosamine, collagen I/IV) with RGDS (Arg-Gly-Asp-Ser) sites for cell adhesion. The HepG2/C3A cell line was cultured under a flow rate of 10 µL/min for 21 days. After seed</pubmed_abstract><journal>Bioengineering (Basel, Switzerland)</journal><pubmed_title>Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver's Extracellular Matrix.</pubmed_title><pmcid>PMC9495334</pmcid><funding_grant_id>ANR-19-CE19-0020-01</funding_grant_id><pubmed_authors>Jellali R</pubmed_authors><pubmed_authors>Le Goff A</pubmed_authors><pubmed_authors>Maes V</pubmed_authors><pubmed_authors>Messelmani T</pubmed_authors><pubmed_authors>Legallais C</pubmed_authors><pubmed_authors>Vandenhaute E</pubmed_authors><pubmed_authors>Roudaut M</pubmed_authors><pubmed_authors>Maubon N</pubmed_authors><pubmed_authors>Leclerc E</pubmed_authors><pubmed_authors>Souguir Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of Liver-on-Chip Integrating a Hydroscaffold Mimicking the Liver's Extracellular Matrix.</name><description>The 3Rs guidelines recommend replacing animal testing with alternative models. One of the solutions proposed is organ-on-chip technology in which liver-on-chip is one of the most promising alternatives for drug screening and toxicological assays. The main challenge is to achieve the relevant in vivo-like functionalities of the liver tissue in an optimized cellular microenvironment. Here, we investigated the development of hepatic cells under dynamic conditions inside a 3D hydroscaffold embedded in a microfluidic device. The hydroscaffold is made of hyaluronic acid and composed of liver extracellular matrix components (galactosamine, collagen I/IV) with RGDS (Arg-Gly-Asp-Ser) sites for cell adhesion. The HepG2/C3A cell line was cultured under a flow rate of 10 µL/min for 21 days. After seed</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-04T21:34:53.218Z</modification><creation>2025-04-04T21:34:53.218Z</creation></dates><accession>S-EPMC9495334</accession><cross_references><pubmed>36134989</pubmed><doi>10.3390/bioengineering9090443</doi></cross_references></HashMap>